Primary systemic amyloidosis as a real diagnostic challenge - case study

被引:4
作者
Jerzykowska, Sonia [1 ]
Cymerys, Maciej [1 ]
Gil, Lidia A. [2 ]
Balcerzak, Andrzej [2 ]
Pupek-Musialik, Danuta [1 ]
Komarnicki, Mieczyslaw A. [2 ]
机构
[1] Poznan Univ Med Sci, Dept Internal Med Metab Dis & Arterial Hypertens, Poznan, Poland
[2] Poznan Univ Med Sci, Dept Haematol, Poznan, Poland
关键词
AL amyloidosis; Congo red stain; bone marrow trepanobiopsy; immunofixation; LIGHT-CHAIN AMYLOIDOSIS; AL AMYLOIDOSIS; HEREDITARY AMYLOIDOSIS; PATHOPHYSIOLOGY; CLASSIFICATION; UPDATE;
D O I
10.5114/ceji.2014.42126
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Primary amyloidosis (AL) is a rare variety of plasma cell dyscrasia, the diagnosis of which is often dfficult to establish. Pathogenesis of amyloidosis involves extracellular deposition of insoluble protein fibrils in tissues, leading to insufficiency of affected organs. According to various sources, mean survival rate of patients with primary amyloidosis ranges from 12 to 24 months, making primary amyloidosis a disease with a very poor prognosis. Survival rate is significantly lowered in case of cardiac manifestation of amyloidosis (about 6 months survival in untreated patients). In recent years a considerable progress in AL treatment has been observed. Nowadays we are able not only to delay progression of amyloidosis, but also to improve the function of the affected organs. Unfortunately as first signs and symptoms of AL are usually nonspecific, the diagnosis of AL is often delayed, resulting in late introduction of optimal therapy. There are many diagnostic tests which can be used in diagnostic process of amyloidosis, i.e. electrophoresis, serum and urine immunofixation or affected organs and bone marrow biopsy. On establishing the diagnosis in a patient with suspected amyloidosis it should be remembered that particular diagnostic methods vary considerably in sensitivity. The aim of this paper is to present a case report of a 27-year-old patient with primary amyloidosis focusing on diagnostic aspect of this condition. On the basis of this case, the authors would like to emphasize the value of precise diagnostic process, with immunological techniques playing undoubtedly a crucial role.
引用
收藏
页码:61 / 66
页数:6
相关论文
共 34 条
  • [1] Updates in Cardiac Amyloidosis: A Review
    Banypersad, Sanjay M.
    Moon, James C.
    Whelan, Carol
    Hawkins, Philip N.
    Wechalekar, Ashutosh D.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2012, 1 (02):
  • [2] A new human hereditary amyloidosis: The result of a stop-codon mutation in the apolipoprotein AII gene
    Benson, MD
    Liepnieks, JJ
    Yazaki, M
    Yamashita, T
    Asl, KH
    Guenther, B
    Kluve-Beckerman, B
    [J]. GENOMICS, 2001, 72 (03) : 272 - 277
  • [3] Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: patients can have both monoclonal gammopathies and hereditary amyloid proteins
    Comenzo, RL
    Zhou, P
    Fleisher, M
    Clark, B
    Teruya-Feldstein, J
    [J]. BLOOD, 2006, 107 (09) : 3489 - 3491
  • [4] Dmoszynska A, 2011, WYDAWNICTWO MED TRIB, P532
  • [5] The classification and typing of amyloid deposits
    Gertz, MA
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 121 (06) : 787 - 789
  • [6] Gertz Morie A, 2004, Hematology Am Soc Hematol Educ Program, P257
  • [7] Immunoglobulin light chain amyloidosis: 2012 update on diagnosis, prognosis, and treatment
    Gertz, Morie A.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (02) : 184 - 189
  • [8] Gil Lidia, 2009, Pol Merkur Lekarski, V27, P181
  • [9] Pathophysiology and treatment of systemic amyloidosis
    Gillmore, Julian D.
    Hawkins, Philip N.
    [J]. NATURE REVIEWS NEPHROLOGY, 2013, 9 (10) : 574 - 586
  • [10] Utility of 18F-FDG PET(/CT) in patients with systemic and localized amyloidosis
    Glaudemans, Andor W. J. M.
    Slart, Riemer H. J. A.
    Noordzij, Walter
    Dierckx, Rudi A. J. O.
    Hazenberg, Bouke P. C.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (07) : 1095 - 1101